Mortality up with CKD in PCI contrast-induced nephropathy

Mortality up with CKD in PCI contrast-induced nephropathy

(HealthDay)—Contrast-induced nephropathy (CIN) is associated with long-term mortality in patients with, but not those without, chronic kidney disease (CKD), according to a study published in the Aug. 1 issue of The American Journal of Cardiology.

Mitsuru Abe, M.D., from the National Hospital Organization Kyoto Medical Center in Japan, and colleagues examined the effect of CIN on long-term mortality after in with or without CKD. Data were included for 4,371 patients who had paired serum creatinine measurements before and after percutaneous coronary intervention.

The researchers found that the incidence of CIN was 5 percent in the study cohort overall, and was 11 percent in patients with CKD and 2 percent in those without CKD (P < 0.0001) A total of 8.6 percent of patients died during a median follow-up of 42.3 months after discharge. CIN correlated with long-term mortality in the entire cohort after adjustment for prespecified confounders (hazard ratio [HR], 2.26; 95 percent confidence interval [CI], 1.62 to 2.29; P < 0.0001). CIN correlated with long-term mortality in patients with CKD (HR, 2.62; 95 percent CI, 1.91 to 3.57; P < 0.0001), but not in patients without CKD (HR, 1.23; 95 percent CI, 0.47 to 2.62; P = 0.6). These results were confirmed in sensitivity analyses.

"In conclusion, CIN was significantly correlated with long-term mortality in patients with CKD but not in those without CKD," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Nonalcoholic fatty liver disease linked to CKD in T1DM

Apr 09, 2014

(HealthDay)—For patients with type 1 diabetes, nonalcoholic fatty liver disease (NAFLD) is independently associated with the risk of incident chronic kidney disease (CKD), according to a study published ...

Recommended for you

Vitamin K antagonist plus clopidogrel feasible for PCI

Sep 19, 2014

(HealthDay)—Vitamin K antagonists (VKA) combined with clopidogrel may be a better alternative to triple anticoagulant therapy in patients on long-term VKA undergoing percutaneous coronary intervention (PCI) ...

How pneumonia bacteria can compromise heart health

Sep 19, 2014

Bacterial pneumonia in adults carries an elevated risk for adverse cardiac events (such as heart failure, arrhythmias, and heart attacks) that contribute substantially to mortality—but how the heart is ...

An autoimmune response may contribute to hypertension

Sep 17, 2014

High blood pressure is a major risk factor for heart attack, stroke, chronic heart failure, and kidney disease. Inflammation is thought to promote the development of high blood pressure, though it is not clear what triggers ...

User comments